Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Prime Capital Investment Advisors LLC

Prime Capital Investment Advisors LLC lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,828 shares of the pharmacy operator’s stock after selling 1,856 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in Walgreens Boots Alliance were worth $97,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Capital World Investors raised its stake in Walgreens Boots Alliance by 57.5% during the 1st quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock valued at $630,334,000 after acquiring an additional 10,612,373 shares in the last quarter. Thompson Siegel & Walmsley LLC raised its stake in Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after acquiring an additional 2,992,648 shares in the last quarter. Newport Trust Company LLC bought a new stake in Walgreens Boots Alliance during the 2nd quarter valued at $31,028,000. Swedbank AB bought a new stake in Walgreens Boots Alliance during the 1st quarter valued at $16,365,000. Finally, Philip James Wealth Mangement LLC bought a new stake in Walgreens Boots Alliance during the 3rd quarter valued at $5,252,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $8.48 on Monday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.22 and a 1-year high of $27.05. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $7.33 billion, a price-to-earnings ratio of -0.85, a P/E/G ratio of 1.11 and a beta of 0.69. The stock’s fifty day simple moving average is $9.19 and its 200-day simple moving average is $11.83.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter in the previous year, the company posted $0.67 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% compared to the same quarter last year. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.79%. Walgreens Boots Alliance’s dividend payout ratio is -9.99%.

Wall Street Analyst Weigh In

Several analysts have weighed in on WBA shares. Bank of America cut their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. Barclays boosted their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. UBS Group boosted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Finally, TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.